Drug Shortage Report for PACLITAXEL INJECTION USP
Report ID | 207557 |
Drug Identification Number | 02391465 |
Brand name | PACLITAXEL INJECTION USP |
Common or Proper name | PACLITAXEL |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | PACLITAXEL |
Strength(s) | 6MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 |
ATC code | L01CD |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-09-14 |
Estimated end date | 2023-11-06 |
Actual end date | 2023-11-13 |
Shortage status | Resolved |
Updated date | 2023-11-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-11-14 | English | Compare |
v4 | 2023-11-10 | French | Compare |
v3 | 2023-11-10 | English | Compare |
v2 | 2023-10-19 | French | Compare |
v1 | 2023-10-19 | English | Compare |
Showing 1 to 5 of 5